Guangzhou, China

Gift Chiwala

This inventor holds 1 USPTO granted patent. Top assignee: Chinese Academy of Sciences. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gift Chiwala. Retrieved from https://idiyas.com/inventor/gift-chiwala

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Gift Chiwala

Introduction

Gift Chiwala is a notable inventor based in Guangzhou, China. He has made significant strides in the field of pharmaceuticals, particularly in the treatment of tuberculosis. His work is recognized for its potential impact on public health.

Latest Patents

Gift Chiwala holds a patent for a groundbreaking invention titled "Construction Method of Recombinant Drug-Resistant Mycobacterium Bovis Bacillus Calmette-Guerin (BCG) Strain and Pharmaceutical Composition for Treating Tuberculosis (TB)." This patent addresses critical challenges in tuberculosis treatment and showcases his innovative approach to combating this disease. He has 1 patent to his name.

Career Highlights

Chiwala is affiliated with the Chinese Academy of Sciences, where he contributes to research and development in the pharmaceutical sector. His work is characterized by a commitment to advancing medical science and improving treatment options for infectious diseases.

Collaborations

Throughout his career, Gift Chiwala has collaborated with esteemed colleagues, including Tianyu Zhang and Bangxing Wang. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Gift Chiwala's contributions to the field of pharmaceuticals, particularly in tuberculosis treatment, highlight his innovative spirit and dedication to improving public health. His work continues to inspire future advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…